ITGB1 and colorectal cancer: This study showed that under the action of ropivacaine, the expression of β1 integrin (ITGB1) in HCT116 and subcutaneous colorectal cancer xenograft tumor model (SW620) cells was significantly reduced, and ropivacaine can inhibit the proliferation, migration, and invasion of colorectal cancer cells.